Hims shares logged their best session in a month and added after-hours gains. ・Novo expanded oral Wegovy access, while Citi ...

This post is brought to you in paid partnership with Hims. We’re one week into the new year. By now, the initial burst of ...

Hims Weight Loss offers personalized clinical programs with GLP-1 injections, medication management, and ongoing support.

Hims & Hers Health, Inc. analysis: subscription health platform growth, GLP-1 risks, and catalysts in women’s health & ...

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the Stocks With Huge Catalysts on the Horizon. On July 9, Hims & Hers Health, Inc. (NYSE:HIMS) announced expanding into Canada with a new affordable ...

MOBILE, Ala. (WALA) - More than 40% of American adults live with obesity, yet personalized, supportive care is often out of reach due to challenges like soaring costs, lack of insurance coverage, or ...

Hims & Hers was rated Hold amid margin pressure, Amazon-driven competition, & uncertain catalysts. Learn more about HIMS ...

Hims & Hers Health Inc (NYSE:HIMS) shares surged in early trading Wednesday before pulling back. The stock was still up marginally at last check after the company announced a planned Canadian ...

Hims & Hers HIMS recently announced that it is expanding access to its comprehensive Weight Loss Program to customers in the United Kingdom. The company is launching its Hers platform to provide ...